Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program.
Cannon CP, Hand MH, Bahr R, Boden WE, Christenson R, Gibler WB, Eagle K, Lambrew CT, Lee TH, MacLeod B, Ornato JP, Selker HP, Steele P, Zalenski RJ; National Heart Attack Alert Program (NHAAP) Coordinating Committee Critical Pathways Writing Group. Cannon CP, et al. Am Heart J. 2002 May;143(5):777-89. doi: 10.1067/mhj.2002.120260. Am Heart J. 2002. PMID: 12040337 Review.
Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarction.
Bahr RD, Gurbel PA, Malinin AI, Wentz C, Christenson RH, Roe MT, Gibler WB, Kitt MM, Ohman EM, Serebruany VL. Bahr RD, et al. Among authors: christenson rh. Am J Cardiol. 2002 Aug 1;90(3):310-2. doi: 10.1016/s0002-9149(02)02470-0. Am J Cardiol. 2002. PMID: 12127619 No abstract available.
Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).
Gurbel PA, Galbut B, Bliden KP, Bahr RD, Roe MT, Serebruany VL, Gibler WB, Christenson RH, Ohman EM; EARLY Platelet Substudy. Gurbel PA, et al. Among authors: christenson rh. J Thromb Thrombolysis. 2002 Dec;14(3):213-9. doi: 10.1023/a:1025048726396. J Thromb Thrombolysis. 2002. PMID: 12913401 Clinical Trial.
A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes.
Roe MT, Christenson RH, Ohman EM, Bahr R, Fesmire FM, Storrow A, Mollod M, Peacock WF, Rosenblatt JA, Yang H, Fraulo ES, Hoekstra JW, Gibler WB; EARLY Investigators; Emergency Medicine Cardiac Research and Education Group. Roe MT, et al. Among authors: christenson rh. Am Heart J. 2003 Dec;146(6):993-8. doi: 10.1016/S0002-8703(03)00517-9. Am Heart J. 2003. PMID: 14660990 Clinical Trial.
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT. Bagai A, et al. Among authors: christenson rh. Am Heart J. 2014 Oct;168(4):503-511.e2. doi: 10.1016/j.ahj.2014.06.008. Epub 2014 Jun 9. Am Heart J. 2014. PMID: 25262260 Clinical Trial.
Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
Beatty AL, Ku IA, Bibbins-Domingo K, Christenson RH, DeFilippi CR, Ganz P, Ix JH, Lloyd-Jones D, Omland T, Sabatine MS, Schiller NB, Shlipak MG, Skali H, Takeuchi M, Vittinghoff E, Whooley MA. Beatty AL, et al. Among authors: christenson rh. J Am Heart Assoc. 2015 Jul 6;4(7):e001646. doi: 10.1161/JAHA.114.001646. J Am Heart Assoc. 2015. PMID: 26150476 Free PMC article.
442 results